SCHEMBL27237484

SCHEMBL27237484

CCCCOc1ccc(-c2cccc(C(=O)NN=Cc3cc(OC)cc(OC)c3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ NPSR1 Q6W5P4 3/20 0.49
▸ MGAM O43451 2/20 0.49
▸ ALDH1A1 P00352 6/20 0.48
▸ HPGD P15428 4/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ MAPT P10636 4/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ MAPK1 P28482 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.44
▸ PLA2G2A P14555 1/20 0.44
▸ TP53 P04637 2/20 0.44
▸ MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002946 1.00 KMT2A (0.56) KMT2AMEN1NPSR1MGAMALDH1A1
SCHEMBL30862205 0.96 KMT2A (0.56) KMT2AMEN1NPSR1MGAMALDH1A1
SCHEMBL27237483 0.96 KMT2A (0.56) KMT2AMEN1NPSR1MGAMALDH1A1
SCHEMBL25003813 0.96 KMT2A (0.56) KMT2AMEN1NPSR1MGAMALDH1A1
SCHEMBL25003158 0.92 KMT2A (0.58) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL27237401 0.92 KMT2A (0.58) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL25003809 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL30951025 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL27237446 0.90 KMT2A (0.69) KMT2AMEN1MGAMALDH1A1HPGD
SCHEMBL29215102 0.89 SCN2A (0.51) KMT2AMEN1NPSR1MGAMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
Send feedback